Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001493152-19-001592

← back to feed
Filed
Feb 8, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2017 · Sep 30, 2017 1.23M sh
Shares Diluted Q3 2017 · Sep 30, 2017 1.15M sh
Shares Diluted Q3 2017 · Sep 30, 2016 1.11M sh
Shares Diluted Q3 2017 · Sep 30, 2016 1.11M sh
Shares Outstanding Q3 2017 · Sep 30, 2017 1.11M sh
Stockholders Equity Q3 2017 · Sep 30, 2017 −$139.55K
Stockholders Equity Q3 2017 · Dec 31, 2016 −$20.83K
Current Liabilities Q3 2017 · Sep 30, 2017 $38.72K
Current Liabilities Q3 2017 · Dec 31, 2016 $20.83K
Total Liabilities Q3 2017 · Sep 30, 2017 $139.55K
Total Liabilities Q3 2017 · Dec 31, 2016 $20.83K
Total Assets Q3 2017 · Sep 30, 2017 $0
Total Assets Q3 2017 · Dec 31, 2016 $0
Eps Diluted Q3 2017 · Sep 30, 2017 $0.00
Eps Diluted Q3 2017 · Sep 30, 2017 −$0.10
Eps Diluted Q3 2017 · Sep 30, 2016 −$0.01
Eps Diluted Q3 2017 · Sep 30, 2016 −$0.02
Eps Basic Q3 2017 · Sep 30, 2017 $0.00
Eps Basic Q3 2017 · Sep 30, 2017 −$0.11
Eps Basic Q3 2017 · Sep 30, 2016 −$0.01
Eps Basic Q3 2017 · Sep 30, 2016 −$0.02
Sga Expense Q3 2017 · Sep 30, 2017 $200
Sga Expense restated Q3 2017 · Sep 30, 2016 $92
Sga Expense Q3 2017 · Sep 30, 2016 $287
Net Income Q3 2017 · Sep 30, 2017 −$2.99K
Net Income Q3 2017 · Sep 30, 2017 −$118.72K
Net Income restated Q3 2017 · Sep 30, 2016 −$8.53K
Net Income restated Q3 2017 · Sep 30, 2016 −$22.66K
Operating Income Q3 2017 · Sep 30, 2017 −$115.4K
Operating Income Q3 2017 · Sep 30, 2016 −$8.53K
Operating Income Q3 2017 · Sep 30, 2016 −$22.66K
Operating Cash Flow restated Q3 2017 · Sep 30, 2016 −$14.11K